[O-31] 一般演題口演セッション31
治療創薬・再生医療１ E

[O-31-5] Benefit of eculizumab for a broad range of patients with NMOSD: findings from the PREVENT study

^○中島 一郎¹, Kazuo Fujihara^2,3, Achim Berthele⁴, Ho Jin Kim⁵, Michael Levy^6,7, Celia Oreja-Guevara⁸, Jacqueline Palace⁹, Sean J. Pittock¹⁰, Murat Terzi¹¹, Natalia Totolyan¹², Shanthi Viswanathan¹³, Kai-Chen Wang^14,15, Amy Pace¹⁶, Marcus Yountz¹⁶, Larisa Miller¹⁶, Imran Tanvir¹⁶, Róisín Armstrong¹⁶, Dean M. Wingerchuk¹⁰ (1.東北医科薬科大学医学部 老年神経内科学, 2.東北大学医学部 神経内科学, 3.福島県立医科大学 多発性硬化症治療学, 4.Technical University of Munich, 5.Research Institute and Hospital, Goyang, 6.Johns Hopkins University, 7.Massachusetts General Hospital, 8.Hospital Universitario Clínico San Carlos, 9.John Radcliffe Hospital, 10.Mayo Clinic, 11.Ondokuz Mayis University, 12.First Pavlov State Medical University of St Petersburg, 13.Kuala Lumpur Hospital, 14.Cheng-Hsin General Hospital, 15.National Yang Ming University, 16.Alexion Pharmaceuticals)